arginine vasopressin has been researched along with naltrexone in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bouvard, MP; Dugas, M; Kerdelhue, B; Launay, JM; Leboyer, M; Lensing, P; Panksepp, J; Tabuteau, F; Waller, D | 1 |
| Fleshner, M; Thurston, CL; Watkins, LR | 1 |
| Van Ree, JM | 1 |
| Devane, GD; Gudelsky, GA; Koenig, JI; Meltzer, HY | 1 |
| Andringa-Bakker, EA; de Wied, D; Goedemans, HJ; van Dam, AF; van Ree, JM; van Wimersma Greidanus, TB | 1 |
| Emmert, SE; Hartman, RD; Miller, DS; Rosella-Dampman, LM; Summy-Long, JY | 1 |
| Chee, O; Keil, LC; Rosella-Dampman, LM; Summy-Long, JY | 1 |
| Berkowitz, BA; Sherman, S | 1 |
| Brooks, DP; Rossi, NF | 1 |
| Hubbard, JI | 1 |
| Endo, T; Fujiwara, Y; Mizutani, R; Sanbe, A; Takagi, N; Takeo, S; Tanoue, A; Tsujimoto, G; Yamauchi, J | 1 |
| Arima, H; Goto, M; Hayashi, M; Hiroi, M; Iwama, S; Murase, T; Oiso, Y; Sugimura, Y | 1 |
1 review(s) available for arginine vasopressin and naltrexone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for arginine vasopressin and naltrexone
| Article | Year |
|---|---|
Brief report: a double-blind study of naltrexone in infantile autism.
Topics: Adolescent; Arginine Vasopressin; Autistic Disorder; beta-Endorphin; Child; Child, Preschool; Dopamine; Dose-Response Relationship, Drug; Double-Blind Method; Epinephrine; Female; Humans; Male; Naltrexone; Norepinephrine | 1992 |
11 other study(ies) available for arginine vasopressin and naltrexone
| Article | Year |
|---|---|
Phenylephrine-induced antinociception: investigations of potential neural and endocrine bases.
Topics: Adrenal Glands; Analgesics; Animals; Arginine Vasopressin; Blood Pressure; Corticosterone; Dexamethasone; Endocrine Glands; Heart Rate; Male; Monitoring, Physiologic; Naloxone; Naltrexone; Neural Pathways; Phenylephrine; Rats; Rats, Inbred Strains; Spinal Cord; Vasopressins | 1990 |
Role of pituitary and related neuropeptides in alcoholism and pharmacodependence.
Topics: Adrenocorticotropic Hormone; Alcoholism; Animals; Arginine Vasopressin; beta-Endorphin; Brain; Endorphins; Haplorhini; Heroin Dependence; Humans; Melanocyte-Stimulating Hormones; Naltrexone; Neurotransmitter Agents; Peptides; Pituitary Gland; Rats; Reinforcement, Psychology; Reward; Substance-Related Disorders | 1986 |
The concentration of arginine vasopressin in pituitary stalk plasma of the rat after adrenalectomy or morphine.
Topics: Adrenalectomy; Animals; Arginine Vasopressin; beta-Endorphin; Dexamethasone; Endorphins; Male; Morphine; Naltrexone; Pituitary Gland; Portal System; Rats; Rats, Inbred Strains | 1986 |
Effects of beta-endorphin fragments on plasma levels of vasopressin.
Topics: Animals; Arginine Vasopressin; beta-Endorphin; Endorphins; Male; Naltrexone; Rats; Rats, Inbred Strains | 1981 |
A functional role for opioid peptides in the differential secretion of vasopressin and oxytocin.
Topics: Animals; Arginine Vasopressin; Dehydration; Endorphins; Female; Hemorrhage; Hypothalamo-Hypophyseal System; Lactation; Male; Naltrexone; Oxytocin; Pregnancy; Rats; Rats, Inbred Strains | 1984 |
Naltrexone effects on plasma vasopressin concentration elevated and lowered by various stimuli.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Hematocrit; Male; Naloxone; Naltrexone; Nicotine; Rats; Rats, Inbred Strains; Sodium; Stress, Physiological; Water-Electrolyte Balance | 1983 |
Characterization of vasopressin analgesia.
Topics: Analgesics; Animals; Arginine Vasopressin; Blood Pressure; Injections, Intraventricular; Male; Mice; Motor Activity; Naltrexone; Rats; Rats, Inbred Strains; Vasopressins | 1982 |
kappa-Opioid agonist inhibition of osmotically induced AVP release: preferential action at hypothalamic sites.
Topics: Animals; Arginine Vasopressin; Culture Techniques; Hypothalamus; Male; Naltrexone; Narcotic Antagonists; Osmotic Pressure; Piperidines; Pituitary Gland, Posterior; Rats; Rats, Inbred Strains; Receptors, Opioid, kappa | 1996 |
Water transport in cultured cells from the rat inner medullary collecting duct.
Topics: Animals; Arginine Vasopressin; Biological Transport; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Kidney Medulla; Kidney Tubules, Collecting; Naltrexone; Narcotic Antagonists; Osmosis; Oxytocin; Pyrrolidines; Rats; Receptors, Opioid, kappa; Water | 1996 |
Alcohol preference in mice lacking the Avpr1a vasopressin receptor.
Topics: Alcohol Drinking; Amino Acids; Animals; Arginine Vasopressin; Central Nervous System Depressants; Dizocilpine Maleate; Ethanol; Excitatory Amino Acid Antagonists; Extracellular Space; Glutamic Acid; In Situ Hybridization; Mice; Mice, Inbred C57BL; Mice, Knockout; Naltrexone; Narcotic Antagonists; Receptors, N-Methyl-D-Aspartate; Receptors, Vasopressin; Sex Characteristics | 2008 |
Central adiponectin functions to inhibit arginine vasopressin release in conscious rats.
Topics: Adiponectin; Animals; Arginine Vasopressin; Blood Pressure; Consciousness; Dose-Response Relationship, Drug; Down-Regulation; Heart Rate; Hypovolemia; Injections, Intraventricular; Male; Naltrexone; Narcotic Antagonists; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Time Factors; Water-Electrolyte Balance | 2009 |